ACMSD anticorps (AA 105-307)
Aperçu rapide pour ACMSD anticorps (AA 105-307) (ABIN1885946)
Antigène
Voir toutes ACMSD AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 105-307
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 105 and 307 of Human ACMSD
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.250 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 20 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- ACMSD (Aminocarboxymuconate Semialdehyde Decarboxylase (ACMSD))
-
Autre désignation
- ACMSD
-
Sujet
-
The neuronal excitotoxin quinolinate is an intermediate in the de novo synthesis pathway of NAD from tryptophan, and has been implicated in the pathogenesis of several neurodegenerative disorders.Quinolinate is derived from alpha-amino-beta-carboxy-muconate-epsilon-semialdehyde (ACMS).ACMSD (ACMS decarboxylase, EC 4.1.1.45) can divert ACMS to a benign catabolite and thus prevent the accumulation of quinolinate from ACMS.[supplied by OMIM]
-
Poids moléculaire
- 38 kDa
-
ID gène
- 130013
-
NCBI Accession
- NM_138326, NP_612199
Antigène
-